Stay updated on RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial

Sign up to get notified when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The trial record displays details about the breast cancer study, including its treatment arms, eligibility criteria, outcomes, study locations, and dates.
    Difference
    64%
    Check dated 2026-11-11T01:09:15.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-03T23:22:12.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH website-transition notice appears above the ClinicalTrials.gov 403 error page, and the displayed site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:50:35.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:51:37.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The 403 error placeholder and the Home navigation were removed, so the study details page can load without encountering the error. This indicates restored access to the study information.
    Difference
    0.5%
    Check dated 2026-09-29T23:01:26.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the usual content and navigation. This prevents viewing the study details and related information.
    Difference
    19%
    Check dated 2026-09-22T23:55:26.000Z thumbnail image

Stay in the know with updates to RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RT+Nivolumab+Ipilimumab vs RT+Capecitabine Clinical Trial page.